What insurance policy changes affect code R62.52?

There are 2 tracked policy changes affecting code R62.52, including updates from Aetna. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code R62.52?

Payers that have issued tracked updates for code R62.52 include: Aetna.

How do I get notified when code R62.52 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code R62.52. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code R62.52?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

PAYER POLICY CHANGES

R62.52 Insurance Policy Changes

ICD-10 R62.52 is officially defined as "Short stature (child)." code R62.52 is referenced in 2 tracked payer policy changes from Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code R62.52 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Only a small number of policies match this filter. Check back as coverage expands.

Aetna · Identified Aug 15, 2026Medium impact
Growth Hormone (GH) and Growth Hormone Antagonists (CPB 0170, reviewed 2026-06-26)
Aetna considers somatropin products (Genotropin, Humatrope, Norditropin, Nutropin AQ, Omnitrope, Saizen and Zomacton), Serostim, Sogroya (somapacitan-beco), Skytrofa (lonapegsomatropin-tcgd) and Somavert (pegvisomant) medically necessary for the listed indications when the criteria for each are met, and considers all other indications experimental, investigational or unproven. The criteria cover pediatric growth hormone deficiency, SGA, Turner syndrome, Prader-Willi syndrome, SHOX deficiency, Noonan syndrome, growth failure from CKD, cerebral palsy, congenital adrenal hyperplasia, cystic fibrosis and Russell-Silver syndrome, adult growth hormone deficiency, HIV-associated wasting or cachexia, and acromegaly. Idiopathic short stature is not considered an illness, so GH is not a covered plan benefit where the plan covers only treatment of disease, illness or injury.
Aetna · Identified Aug 14, 2026Medium impact
Distraction Osteosynthesis (CPB 0220, reviewed 2026-04-09)
Aetna considers the Ilizarov method for distraction osteosynthesis medically necessary for members with an angular or rotational deformity of a long bone, a bone defect, or a limb length discrepancy who also meet one of the listed selection criteria, such as a leg length discrepancy of more than 4 cm, an arm length discrepancy of more than 5 cm, or a long bone fracture not healed in 6 or more months after electrical stimulation and bone grafting have failed. The PRECICE intramedullary limb lengthening system is considered medically necessary for lengthening the tibia and femur in persons with a leg length discrepancy of more than 4 cm. Ilizarov use for other indications, the intramedullary skeletal kinetic distractor, pulsed ultrasound as an adjuvant therapy, and Phenix nails are considered experimental, investigational or unproven, and Ilizarov use to correct short stature is considered cosmetic.

Watch R62.52

Get one email when a payer policy names R62.52, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

Growth Hormone (GH) and Growth Hormone Antagonists (CPB 0170, reviewed 2026-06-26)

Distraction Osteosynthesis (CPB 0220, reviewed 2026-04-09)

What insurance policy changes affect code R62.52?

Which payers have updated policy for code R62.52?

How do I get notified when code R62.52 policy changes?

Why do payers change policies for code R62.52?